Compared with tumor samples, the concordance rate of detecting EGFR sensitive mutations in the sputum cfDNA were 100%, 40.0%, and 25.0% in three sputum groups of malignant, satisfactory but no malignant cells, and unsatisfactory, respectively. Here, EGFR is linked to neoplasm.